Relapse is the major cause of treatment failure after allogeneic hematopoietic cell transplantation (alloHCT) for acute leukemia and myelodysplastic syndrome (MDS). Wilms' tumor Ag (WT1) is ...
ORLANDO, Florida — A first-of-its-kind study has shown that for patients with follicular lymphoma (FL), measurements of minimal residual disease (MRD) can be used to predict risk for relapse.
Whether you’ve recently received a diagnosis of Hodgkin’s lymphoma or you’re nearing the end of your treatment regimen, you may have questions about “remission” and “relapse.” Remission is a term that ...
May 1, 2012 (New Orleans, Louisiana) — Results of a large randomized trial have shown that the combination interferon beta-1a and glatiramer acetate was not more effective than either agent alone on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results